Table 4 Association of PAPP-A with IGFBP-5 with additional adjustment for IGF-1 or other IGFBPs.
n | β per log-transformed PAPP-A (values above detection limit) | 95% CI | β per log-transformed PAPP-A (values below detection limit substituted)) | 95% CI | |
---|---|---|---|---|---|
IGFBP-5, ng/mL‡ | |||||
As in Table 3 | 125 | 1.97 | (1.26, 3.12) | 1.69 | (1.25, 2.29) |
- Plus adjustment for IGF-1 | 125 | 1.98 | (1.27, 3.10) | 1.68 | (1.24, 2.26) |
- Plus adjustment for IGFBP-2 | 125 | 1.97 | (1.25, 3.11) | 1.66 | (1.23, 2.26) |
- Plus adjustment for IGFBP-3 | 125 | 1.99 | (1.26, 3.15) | 1.71 | (1.26, 2.32) |
In participants with available IGFBP-1 | 116 | 2.08 | (1.31, 3.31) | 1.97 | (1.44, 2.69) |
- Plus adjustment for IGFBP-1 (log-transformed) | 116 | 2.08 | (1.31, 3.31) | 1.96 | (1.44, 2.69) |
In participants with available free IGF-1 | 110 | 1.87 | (1.18, 2.95) | 1.52 | (1.11, 2.08) |
- Plus adjustment for free IGF-1 (log-transformed) | 110 | 1.83 | (1.16, 2.91) | 1.48 | (1.08, 2.04) |
- Plus adjustment for free to total IGF-1 (%, log-transformed) | 110 | 1.85 | (1.17, 2.95) | 1.50 | (1.10, 2.07) |